RXRB expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.117200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.862420E-01
Normal-vs-Stage2
3.022800E-01
Normal-vs-Stage3
1.167160E-01
Normal-vs-Stage4
2.572200E-01
Stage1-vs-Stage2
4.878600E-01
Stage1-vs-Stage3
2.090200E-01
Stage1-vs-Stage4
9.748600E-01
Stage2-vs-Stage3
2.549400E-01
Stage2-vs-Stage4
5.931200E-01
Stage3-vs-Stage4
2.463000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.136800E-01
Normal-vs-AfricanAmerican
2.919400E-01
Normal-vs-Asian
3.152600E-01
Caucasian-vs-AfricanAmerican
7.690200E-01
Caucasian-vs-Asian
9.254800E-01
AfricanAmerican-vs-Asian
8.223400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.068000E-01
Normal-vs-Female
3.208600E-01
Male-vs-Female
6.580000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.046200E-01
Normal-vs-Age(41-60Yrs)
3.296200E-01
Normal-vs-Age(61-80Yrs)
2.974000E-01
Normal-vs-Age(81-100Yrs)
1.664960E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.821000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.155600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.741400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.476600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.739200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.354000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.993800E-01
Normal-vs-Daily Drinker
2.382600E-01
Normal-vs-Weekly Drinker
3.032000E-01
Normal-vs-Occasional Drinker
1.376390E-01
Normal-vs-Social Drinker
3.208800E-01
Non Drinker-vs-Daily Drinker
1.939790E-01
Non Drinker-vs-Weekly Drinker
9.641000E-01
Non Drinker-vs-Occasional Drinker
2.878400E-01
Non Drinker-vs-Social Drinker
7.254400E-01
Daily Drinker-vs-Weekly Drinker
2.131800E-01
Daily Drinker-vs-Occasional Drinker
4.894000E-02
Daily Drinker-vs-Social Drinker
1.066620E-01
Weekly Drinker-vs-Occasional Drinker
3.893600E-01
Weekly Drinker-vs-Social Drinker
7.530600E-01
Occasional Drinker-vs-Social Drinker
4.775400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.058590E-01
Normal-vs-Grade 2
3.784100E-02
Normal-vs-Grade 3
5.338000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.415400E-01
Grade 1-vs-Grade 3
7.423200E-01
Grade 1-vs-Grade 4
1.058590E-01
Grade 2-vs-Grade 3
8.570400E-01
Grade 2-vs-Grade 4
3.784100E-02
Grade 3-vs-Grade 4
5.338000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.726600E-01
Normal-vs-NonDiabetic
3.122400E-01
Diabetic-vs-NonDiabetic
2.258000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.815000E-01
Normal-vs-NoPancreatitis
2.954600E-01
Pancreatitis-vs-NoPancreatitis
7.417000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.369000E-01
Normal-vs-N1
2.964600E-01
N0-vs-N1
2.708400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.618800E-01
Normal-vs-TP53-NonMutant
4.406600E-01
TP53-Mutant-vs-TP53-NonMutant
1.680640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
